Literature DB >> 11261738

Hyperthyroidism and concurrent thyroid carcinoma.

M Ruggieri1, F Scocchera, M Genderini, A Mascaro, B Luongo, A Paolini.   

Abstract

In the last twenty years, medical studies have reported a significant increase in thyroid neoplasms among patients with hyperthyroidism. Aim of the present work is to reconsider the real incidence of this not uncommon association and to establish a model for surgical treatment of hyperthyroidism for a possible concurrence with thyroid carcinoma. At the Department of Surgical Sciences and Applied Medical Technologies "La Sapienza" Rome's University, during the period 1994 to 1999, an homogeneous group of 82 patients was surgically treated for hyperthyroidism. Of our patients, fifty-four (66%) had a "multinodular toxic goiter" (MTG), twenty (24%) a "functional autonomous nodule" (FAN) while the remaining patients were affected by Graves' disease. The surgical procedures adopted were: 1) total extracapsular ipsilateral lobectomies and isthmectomies in sixteen patients with FAN; 2) total extracapsular thyroidectomy in all patients with MTG and with Graves' disease and in the remaining four patients with FAN after a long time treatment with thyrostatic drugs. On six (7%) of our patients we found out a thyroid carcinoma: five with MTG and one with Graves' disease. However, no association with thyroid carcinoma was observed in anyone with FAN. The correct treatment of thyroid surgical diseases is a single definitive operative approach. The procedure must be a total thyroidectomy in MTG and Graves' disease. However, in patients with FAN it's possible, after careful evaluation, to carry out a total extracapsular ipsilateral lobectomy with isthmectomy, justified by the normal morphology of the remaining thyroid tissue. It is always possible, in these cases, a subsequent complete exeresis if a carcinoma is present in the removed lobe.

Entities:  

Mesh:

Year:  1999        PMID: 11261738

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

Review 1.  Papillary thyroid carcinoma in an autonomous hyperfunctioning thyroid nodule: case report and review of the literature.

Authors:  Hala M Tfayli; Lisa A Teot; Justin A Indyk; Selma Feldman Witchel
Journal:  Thyroid       Date:  2010-09       Impact factor: 6.568

2.  Can we still consider thyroid hyperfunction a protective condition for the onset of thyroid cancer?

Authors:  Elena Bonati; Stefania Bettoni; Tommaso Loderer; Paolo Del Rio
Journal:  Gland Surg       Date:  2021-04

3.  Clinicopathologic features and treatment outcomes in differentiated thyroid carcinoma patients with concurrent Graves' disease.

Authors:  Jandee Lee; Kee Hyun Nam; Woung Youn Chung; Euy-Young Soh; Cheong Soo Park
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

4.  Concurrent hyperthyroidism and papillary thyroid cancer: a fortuitous and ambiguous case report from a resource-poor setting.

Authors:  Benjamin Momo Kadia; Christian Akem Dimala; Ndemazie Nkafu Bechem; Desmond Aroke
Journal:  BMC Res Notes       Date:  2016-07-26

5.  Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves' disease: a systematic review and meta-analysis of cohort studies.

Authors:  Qingyi Jia; Xiaodan Li; Ying Liu; Ling Li; Joey Sw Kwong; Kaiyun Ren; Yong Jiang; Xin Sun; Haoming Tian; Sheyu Li
Journal:  Cancer Manag Res       Date:  2018-05-21       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.